Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3740618019 | Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
3740619010 | Product containing only hydralazine and hydrochlorothiazide and reserpine in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Has active ingredient | Hydralazine | true | Inferred relationship | Some | 1 | |
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Has active ingredient | Reserpine | true | Inferred relationship | Some | 2 | |
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Is a | Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form | true | Inferred relationship | Some | ||
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Has active ingredient | Hydrochlorothiazide | true | Inferred relationship | Some | 3 | |
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Is a | Hydralazine and hydrochlorothiazide and reserpine only product | true | Inferred relationship | Some | ||
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | True | Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets